Loratadine Guidelines for Use in Allergies
Standard Dosing and Administration
Loratadine is dosed at 10 mg once daily for adults and children ≥6 years, and 5 mg once daily for children 2 to under 6 years of age, with dose adjustments required for patients with liver or kidney disease. 1
- For children under 2 years of age, consult a physician before use 1
- The medication provides rapid symptom relief with onset of action within 1 hour and duration of at least 24 hours 2
- Once-daily dosing improves adherence compared to multiple-daily-dosing antihistamines 3
Hepatic and Renal Impairment
Patients with liver or kidney disease must consult a physician before using loratadine, as dose adjustments are necessary. 1
- Loratadine should be used with caution in severe renal impairment 4
- The FDA label explicitly requires medical consultation for consumers with liver or kidney disease before initiating therapy 1
Pregnancy and Breastfeeding
Loratadine is considered safe during pregnancy, including the first trimester, based on large birth registries, case-control studies, and cohort studies showing no significant increase in congenital malformations. 4
- Second-generation antihistamines like loratadine offer the advantage of less sedation compared to first-generation agents like chlorpheniramine, making them preferable from a quality of life perspective 4
- Loratadine is FDA Pregnancy Category B 5
- Avoid combining loratadine with oral decongestants (phenylephrine, pseudoephedrine) during the first trimester due to associations with gastroschisis and small intestinal atresia 4
- The risk of malformations increases when decongestants are combined with acetaminophen or salicylates 4
Clinical Efficacy
Loratadine demonstrates superior efficacy to placebo and comparable effectiveness to other antihistamines for allergic rhinitis and chronic urticaria. 6
- In pediatric allergic rhinitis, loratadine 5-10 mg once daily significantly improved total symptom scores at day 7 and day 21 compared to placebo (p = 0.003, p = 0.06) 7
- Loratadine is faster acting than astemizole and as effective as azatadine, cetirizine, chlorpheniramine, clemastine, hydroxyzine, mequitazine, and terfenadine 6
- No tachyphylaxis develops during treatment, with efficacy maintained over 14-day courses of therapy 8
Safety Profile
Loratadine is well tolerated with sedation occurring less frequently than with first-generation antihistamines, and serious ventricular arrhythmias have not been observed. 6
- At 10 mg daily dosing, commonly reported adverse events include somnolence, fatigue, and headache, occurring at rates similar to placebo 6
- Sedation occurs less frequently with loratadine than with azatadine, cetirizine, chlorpheniramine, clemastine, and mequitazine 6
- Even high-dose exposures (300 mg in a 6-year-old) resulted only in minor elevation of blood pressure and heart rate when managed with supportive care 9
- Loratadine does not impair driving ability or work performance at recommended doses, unlike first-generation antihistamines which increase fatal accident risk by 1.5 times 3
Combination Therapy Considerations
When nighttime symptoms or sleep disturbance are problematic, loratadine can be combined with a sedating antihistamine like hydroxyzine at bedtime. 5
- Use loratadine 10 mg in the morning for daytime coverage without sedation 5
- Add hydroxyzine 10-50 mg at bedtime specifically for patients with urticaria and sleep disturbances 5
- This combination is most useful when sleep disturbance is a significant problem, not primarily for enhanced antihistamine effect 5
Important Clinical Caveats
Loratadine must be discontinued 7 days before oral food challenge testing to avoid interference with interpretation of results. 10